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Abstract
In this paper, we carry out a computational study using the
spectral decomposition of the fluctuations of a two-pathogen epidemic
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1 Introduction
In this paper, we study the impact of partial vaccination and between-host
pathogen interaction on early pathogen replacement in a two-pathogen
epidemic model of influenza and respiratory syncytial virus (RSV).
It is known that influenza and RSV peak during the winter season in
temperate regions, and have semi-annual activity near tropical areas [9].
Second, the outbreak interference between these viruses have been registered
by years [4–6, 15, 29, 35]. Influenza is known to interact with other viruses,
including RSV. Glenzen et al [15] studied the interaction between influenza
and other respiratory viruses; one of their conclusions is that simultaneous
viral infections are a competition for resources and the virus with the largest
growth rate is the one that succeeds in the invasion. There are also in vitro
experiments presented by Shinjoh et al [29] who have shown that the growth
of RSV can be blocked by influenza A if they infect the host cells at the same
time. In contrast, RSV can suppress the growth of influenza A if this occurs
after RSV infection. Third, the effect of vaccination on epidemic synchrony
patterns has been analyzed for several diseases. In particular, Rohani et
al. [25] have shown that vaccination turned synchronous epidemics (measles)
into irregular and spatially uncorrelated epidemics once vaccination
was deployed, while whooping cough shifted from incoherence and spatial
irregularity to regular dynamics as vaccination was introduced. Furthermore,
in the context of vaccine-induced strain replacement, Martcheva et al [21]
claim that “...the deployment of vaccination changes the proportion of hosts
susceptible to either strain, ultimately shifting their relative and absolute
abundances...”. On the other hand, Alonso et al [3] explain transitions in
epidemics between regular and irregular dynamics in terms of amplification
of demographic noise.
Based on the above results, in this paper, we have proposed a
two-pathogen epidemic model with seasonality and partial vaccination as a
continuous-time Markov jump process using typical kinetic parameter values
of influenza and RSV. Furthermore, we have used standard theoretical and
computational methods [1,3,7,17,30] to show that variations in coverage and
efficacy of influenza vaccination may explain early pathogen replacement,
e.g. either pathogen might invade first, and there is a second wave of
infections where the second pathogen is dominant, see Anestad [4, 5].
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The joint probability distribution of the state variables in our model
is governed by a forward Kolmogorov equation [13]. The van Kampen
asymptotic expansion [31] applied to this equation separates state variables
into a mean field equation that matches the thermodynamic limit of the
stochastic process (and is amenable to stability analysis in the sense of van
den Driessche and Watmough [30]), and a Fokker-Plank equation governing
the system fluctuations, which is equivalent to a Langevin equation in a
neighborhood of the system attractor, e.g., steady state or limit cycle [3, 7].
First, we have used the mean field equation to carry out a standard
analysis of the disease-free equilibrium in terms of the effective vaccination
rate and cross-immunity parameter.
Next, we have applied the Mckane approximation [22] of the power
spectral density (PSD) of the system fluctuations in a neighborhood of
the system attractors [3, 7, 26–28]. Of note, this method of McKane to
approximate the spectral decomposition of the system fluctuations is
well suited to examine the role of between-host pathogen interaction and
partial vaccination in seasonal patterns of respiratory diseases beyond the
qualitative analysis of the mean field equation. Although, care must be
taken since the PSD approximation does not hold near bifurcation points.
Coexistence of stable attractors in one and two pathogen epidemic
models with seasonality has been documented [17, 19] at high contact rates.
Likewise, it has been established that the intertwined basin of multiple
attractors at low contact rate, or high vaccination the rate is not robust to
spatial coupling [3]. Since in this paper, we care about the role of partial
vaccination in seasonal epidemics, we shall focus our analysis in the yearly
regime in a two-pathogen epidemic model with low spatial coupling aiming
at showing a route to pathogen switching in early epidemic season.
The paper is organized as follows. Section 2 describes the mathematical
model and the power spectral density for both seasonally forced and unforced
models. Section 3 shows the results when some key epidemic parameters are
varied. Finally, Section 4 discusses our findings and offer some perspectives.
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2 Theoretical background
2.1 A Two-pathogen Epidemic Model with Partial
Vaccination
The nonlinear dynamics of infectious disease spread in communities is
stochastic. Assuming spatial homogeneity, the populations of susceptible,
infectious and recovered individuals follow a birth and death process in Nn.
Consequently, the epidemic model is posed as a continuous-time Markov
jump process, whose forward Kolmogorov equation is known as the Chemical
Master Equation (CME).
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Figure 1: SIR model with two pathogens. The first subscript denotes the
infection status of influenza and the seconds subscripts denotes the infection
status of RSV. Labels by the arrows represent the reaction rates for each
reaction type. Parameter definitions and dimensions are summarized in
Table 1.
To model the dynamics of two pathogens with partial vaccination, we
extend a SIR model following [3] and [17]. Let Xkl(t) denote the number of
individuals at time t in immunological status k ∈ {S, I, R} for pathogen 1
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(Influenza) and immunological status l ∈ {S, I, R} for pathogen 2 (RSV).
Reactions are illustrated in Figure 1.
We use mass action with contact rates β1 and β2 to describe the flow
of newly infected individuals from the susceptible group to the group of
individuals infected with influenza or RSV respectively. The low spatial
coupling is modeled with the immigration of infectious individuals with either
disease at rate η. The average residence time for both diseases is 1/γ = 7
days [11]. The population is assumed constant Ω. Therefore, we have set
the birth rate equal to µΩ, while life expectancy is set equal to 1/µ = 70
years [36]. Vaccination is not completely effective. Thus υ represents the
effective vaccination rate. Vaccinated people either go to the recovered
class XRS (concerning influenza) or remain in the susceptible class XSS
depending on the vaccine efficacy. On the other hand, λ1 and λ2 represent
the population infected with influenza and RSV respectively. Finally, to
describe the relationship between RVS and influenza, we use a parameter
σ to describe either cross-immunity or cross-enhancement [1, 17]. There is
pathogen cross-immunity when 0 < σ < 1. This indicates that the presence of
either pathogen inhibits the presence of the other one. σ = 0 confers complete
protection against a secondary infection and σ = 1 confers no protection.
While σ > 1 represents increasing the degree of cross-enhancement, i.e., the
presence of either pathogen enhances the presence of the other one [1].
Name Symbol Value Dimension
Baseline contact rate βi, i = 1, 2 year
−1
Fraction of infectious individuals λi, i = 1, 2 1
Cross immunity coefficient σ [0, 2] 1
Effective vaccination rate υ [0, 1] year−1
Immigration rate η 12 year−1
Death/birth rate µ 1/70 year−1
Recovery rate γ 52.14 year−1
Table 1: Two pathogen model parameters. Here βi, for i = 1, 2 is the contact
rate for influenza and RSV respectively.
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2.1.1 Chemical Master Equation
Let us consider a closed population of size Ω at a given time t, well mixed and
homogeneously distributed, where individuals interact via R = 25 reactions
depicted in Figure 1. Transitions between states depend only on the time
interval but not on absolute time, i.e., X(∆t) and X(t + ∆t) − X(t) are
identically distributed. Additionally, two or more transitions take place in the
same time interval with zero probability. Finally, for small time increments
∆t, the transition probabilities aj(y) are obtained by multiplying the rates
shown in Figure 1 by ∆t, see [2, 14]. These assumptions are encoded in
the Kolmogorov forward equation (Chemical Master Equation, or CME). It
represents the evolution of the probability distribution of finding the system
in state X = x at time t.
dPx(t)
dt
=
R∑
j=1
aj(x− vj)Px−vj(t)−
R∑
j=1
aj(x)Px(t) (1)
where x(t) corresponds to the realizations of the random vector X(t) =
[Xi(t)] and vj(t) are the stoichiometric vectors e.g. vectors whose elements
in {−1, 0, 1} describe the addition/subtraction of mass from a particular
compartment. Let S = Sij, i = 1, ..., 5; j = 1, ...,R be the stoichiometric
matrix that describes changes in the population size due to each of the R
reactions and S = [v1, . . . , vR]. A list with the R reactions and the explicit
form of these terms are defined in the supplementary material.
2.1.2 Seasonal Forcing
Often, in order to analyze the full time-dependent master equation for the two
pathogens model with seasonal forcing, authors describe the system dynamics
using the same equations, e.g. equations (1) and (5), except that β1 and β2
are functions of time, i.e.,
βp(t) = βi(1 + δ cos(2pit/T )) (2)
for p, i = 1, 2. Parameters βi, are the baseline contact rate, δ is the
magnitude of seasonal forcing and T is the period of one year.
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2.2 Theoretical and computational tools
2.2.1 Van Kampen Expansion
For large populations, equation (1) is computationally too expensive to be
solved exactly. Hence, we assume that the linear noise approximation holds
X(t) = Ωφ(t) + Ω1/2ξ(t), t ∈ [0, T ], (3)
namely, for large Ω the system states X = x can be expressed as
the sum of a macroscopic term φ(t) and a stochastic term ξ(t), which
describes the fluctuations and accounts for demographic stochasticity in the
system. Combining equations (1) and (3) gives rise to the van Kampen
expansion [31]. Assuming constant average concentration, the size of the
stochastic component will increase as the square root of population size.
The time-evolution of the terms of order Ω1/2 [31] is governed by the ODE
system
dφi(t)
dt
=
R∑
j=1
Sijfj(φ(t), t)
φi(0) = φ0
(4)
where t ∈ [0, T ], i = 1, . . . , dim{X(t)}, φi(t) = limΩ,X−→∞Xi/Ω, and
fj(φ(t), t) = aj(φ(t)). Collecting terms of order Ω
0, we obtain a Fokker Plank
equation for the joint distribution of the system fluctuations, see [31]. Of
note, there is a well known Langevin equation, which describes the temporal
evolution of the normalized fluctuation of susceptible and infectious states [3],
and whose solution is the same as the Fokker-Planck equation for the system
fluctuations in a neighborhood of the macroscopic steady state
ξ˙(t) = A(t)ξ(t) + ζ(t) (5)
where ζ(t) is white noise with zero mean and correlation structure given
by 〈ζ(t)ζ(t′)T 〉 = B(t)δ(t−t′). Here, A(t) = ∂Sf(φ(t), t)/∂φ(t), B(t) = EET
and E = S diag{√f(φ(t), t)}, see [14,18,31].
2.2.2 Power Spectral Density
We consider both, seasonally forced and unforced models. Our contributions
rest on examining how the natural frequency of the epidemic outbreak varies
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when some key epidemic parameters are changed [34]. Consequently, in this
Subsection, we describe the method first introduced by Newman and Mckane
[24] to compute the analytical PSD in a neighborhood of the system attractor
(steady state or limit cycle) to a two pathogen model.
2.2.3 Unforced Model
We consider the power spectral density of the fluctuations obtained through
Wiener-Khinchin theorem, [12] by Fourier transforming linear stochastic
differential equation (5)
Pk(ω) = 〈|ξ˜k(ω)|2〉
formally
ξ˜k =
∫ ∞
−∞
ξk(t)e
−kωtdt
for k = 1, . . . , 5. Rozhnova [26], [27] provides a closed expression for the
PSD in terms of matrices A and B obtained by the van Kampen expansion.
To compute the PSD, matrices A and B are evaluated at the steady state of
the system (4). The general solution is given by
Pkl(ω) =
∑
i,j
Φkj(ω)BjiΦ
†
il(ω), (6)
Φ†(ω) = (ΦH)−1 means the inverse of the conjuate transpose of Φ where
Φ(ω) = −iωI−A. Equation (6) allows to compute the PSD for a wide range
of frequencies and parameter ranges with moderate computational burden.
2.2.4 Forced Model
Matrices A(t) = A(t + T ) and B(t) = B(t + T ) are now periodic functions
of time, instead of the method used in Subsection 2.2.3, we use Floquet’s
theory to find the solution of Eqs. (5) and compute its power sprectrum
density, see [7].
The solution of equation (5) can be written as a sum of the general
solution of the homogeneous and a particular solution of the inhomogeneous
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system getting
dΦ(t)
dt
= A(t)Φ(t) (7)
Where Φ(t) is the fundamental matrix [16], formed from the linearly
independent solutions of homogeneous equation ξ˙(t) = A(t)ξ(t). Floquet’s
theorem states that there exists a periodic non singlular matrix M [16] such
that
Φ(t+ T ) = Φ(t)M
Matrix M is sometimes referred as the monodromy matrix of the
fundamental matrix Φ(t). This can be expressed in terms of the fundamental
matrix by setting t = 0
M = Φ−1(0)Φ(T ) (8)
It is useful to choose Φ(t) to be the principal matrix, so that Φ(0) = I, and
then M = Φ(T ). The eigenvalues of M , ρ1, . . . , ρn, are called the caracteristic
multipliers and a related set of quantities are the Floquet exponents defined
by
ϑi =
ln(ρi)
T
(9)
Of note, a limit cycle will be stable if |ϑi| < 1, see [28], [16]. Using
further Floquet’s theory and analytical expression, it is possible to obtain the
auto-correlation function of the stochastic fluctuations [7], [10], [28], given by
C(τ) =
1
T
∫ T
0
〈ξ(t+ τ)ξ′(t)dt〉, ξ ≡ {ξ1, . . . , ξ5} (10)
Taking the Fourier transform of this expression, we get an exact
expression for power spectrum of the stochastic oscillations. The details
are presented in references [7, 10] and the algorithm to compute the PSD is
described by Black [8] (p. 111).
2.2.5 Coherence
Based on Alonso et al [3] definition of coherence as a measure of stochastic
amplification, we consider the normalized cross-correlation as a measure of
similarity of influenza and RSV spectral densities
Qkl(ω) =
Pkl(ω)√
Pk(ω)Pl(ω)
, (11)
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where we denote Pkl(ω) = Pk(ω) if k = l. In Section 3 we use equation
(11) to examine the out of phase relationship and correlation of influenza
and RSV signals as a function of vaccination and cross-immunity rates at
selected frequency ranges.
3 Results
To carry out our analysis of the two pathogen model, we take a simplified
Markov jump process whose elements are defined in terms of the Markov
process defined in Figure 1 using the following identities
Y1(t) = XSS(t)
Y2(t) = XIS(t) +XII +XIR(t)
Y3(t) = XSI(t) +XII +XRI(t)
Y4(t) = XIS(t) +XRS(t)
Y5(t) = XSI(t) +XSR(t)
where the Yi, i = 1, ..., 5 represent respectively, the number of those
individuals who are susceptible to both pathogens, those who are infected
with influenza only, those who are infected with RSV only, those who are
susceptible to RSV and those who are susceptible to influenza respectively.
3.1 Role of seasonality on system fluctuations
According to Rozhnova and Nunes [28], using Floquet’s theory described in
(2.2.4) we can show that the power spectral density has peaks at frequencies
m
T
± |Im(ϑp)|
2pi
, p = 1, 2 (12)
where m is an integer and ϑp are the Floquet exponents. For the annual
limit-cycle the dominant peak is at Im(ϑp)/2pi, with the others peaks being
much smaller. Here, |Im(ϑp)| denotes the absolute value of the imaginary
part of complex conjugate Floquet exponents.
Figure 2 shows the analytic PSD with and without seasonal forcing.
The parameters values are β1 = 93.88 year
−1, β2 = 83.45 year−1,
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Figure 2: PSD without and with seasonal forcing. Vertical helper
lines mark the frequencies predicted by Eq. (12). The parameters values
are β1 = 93.88 year
−1, β2 = 83.45 year−1, σ = 0.8, δ = 0.06 and υ =
0. The Floquet exponents are ϑ1 = −0.01341813 ± 0.74852756i and ϑ2 =
−0.01071943 + 0.58598082i and ϑ3 = −0.02753316 + 0.i.
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σ = 0.8, δ = 0.06 and υ = 0. Floquet exponents are given by
ϑ1 = −0.01341813 ± 0.74852756i and ϑ2 = −0.01071943 + 0.58598082i and
ϑ3 = −0.02753316 + 0.i. Thus, the dominant peak for Influenza is given
by Im(ϑ1)/2pi = 0.119131 year
−1 and the mean peak for RSV is given by
Im(ϑ2)/2pi = 0.0932 year
−1. We can see that the PSD for the non-seasonal
case are qualitatively comparable with the PSD obtained for the seasonally
forced system. The main difference is the addition of two annual peaks with
seasonal transmission. The period for both peaks of influenza are 0.893549
and 1.1352436 year and the period for the RSV peaks are 0.914694 and
1.1028540 year.
Bifurcation diagram (not shown), indicates that there is a period doubling
bifurcation as we increase either σ, or δ. However, in the one hand we care
about pathogen replacement during the early season epidemics. And on the
other hand, the PSD analytic formulas do not hold near bifurcation points.
Consequently, we limit our analysis to the yearly regime.
3.2 Epidemic criticality conditions
Since seasonal and epidemic fluctuations are separated as indicated in Figure
2, in the remainder we focus on the analysis of the epidemics fluctuations. Let
us analyze the steady states of the system without seasonality to understand
the relationship between effective vaccination and cross-immunity. In terms
of the deterministic model (4), the largest eigenvalue of the next generation
matrix, or basic reproductive number is
R0 = max
i=1,2
Ri (13)
where, R1, R2 given by
R1 =
µβ1
(γ + µ)(µ+ υ)
R2 =
β2(µ+ συ)
(γ + µ)(µ+ υ)
(14)
are the two only eigenvalues of the next generation matrix of van den
Driessche and Watmough [30] (see supplementary material for details). The
two eigenvalues correspond to the reproduction numbers for each pathogen,
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R1 for influenza and R2 for RSV. If η = 0 system (4) has a disease free
equilibrium (YDFE)
YDFE = [µ/(µ+ υ), 0, 0, υ/(µ+ υ), 0]. (15)
The disease-free equilibrium is stable if R0 < 1 and unstable if R0 > 1.
There is a steady state where only people infected with influenza is present,
and similarly, there is a steady state where only people infected with RSV is
present. Also, there is a steady state where both diseases coexist. We base
this claim on Vasco et al [32] analysis of the case with no vaccination.
3.3 Analysis of cross-immunity
Let us study the disease-free equilibrium (15), and conditions under which
it is possible to eradicate both diseases assuming that there is no seasonal
forcing. We will focus on the cross-immunity σ and the effective vaccination
rate υ.
The equilibrium point YDFE is stable if R0 < 1. Of note, R1 and R2
dependence on υ imply that by increasing the effective vaccination value
we may reduce R0 below 1, thus erradicating both diseases, even when
vaccination is only against influenza. R0 < 1 implies R1 < 1 and R2 < 1. We
explore the scenarios that may take place given the conditions of stability
for the free-disease equilibrium, i.e. R1 < R2 < 1 and R2 < R1 < 1.
Consequently, we will plot the PSD for selected vaccination values in each
case.
If we consider the case when R1 < R2 < 1, the conditions to effective
vaccination rate and cross-immunity are
• υ > µ(β2 − (γ + µ))
(γ + µ− σβ2)
• σ < γ + µ
β2
< 1
On the other hand, if we consider the case R2 < R1 < 1 we have:
• υ > µ(β1 − (γ + µ))
(γ + µ)
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• σ < γ + µ
β2
< 1
• β1 > (γ + µ)
There are three cases to consider,
Case σ < 1. See Fig. 3. This condition assumes that getting sick from
either virus confers some protection against the second one. Let us
denote R1 and R2 respectively the values of R1 and R2 without the
presence of effective vaccination, i.e. R1 = β1
γ + µ
and R2 = β2
γ + µ
.
Furthermore, let us consider the starting point in parameter space
where R1 = 1.6 and R2 = 1.23. This implies β1 = 83.45 year−1 and
β2 = 64.15 year
−1. Let us set σ = 0.8. With these values, σ and
υ satisfy the condition above. Thus, the effective vaccination rate
values for vanish both viruses are υ = 0.008571 year−1 for influenza
and υ = 0.2053999 year−1 for syncytial. This means that when there
is some kind of cross-immunity between these viruses, it is possible
to control both, even when vaccine acts only against influenza. On
the other hand, it is possible to find vaccination values that, while
decreasing the amplification of influenza, increase the amplification of
RSV. It is noteworthy that there is a vaccination value (υ ≈ 0.0073)
where the PSD peak for both diseases trade places. Of note, this
phenomenon has been observed in real data, e.g., [23].
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Figure 3: Power Spectral Density for the case σ < 1. This figure shows
how the PSD for influenza and RSV vanish when crossing the respective
thresholds υ = 0.008571 and υ = 0.2053999 year−1. PSD is shown at selected
vaccination rates.
Case σ = 1 In this case the behavior of both pathogens is independent of
each other. Note that R2 =
β2
γ + µ
, i.e., it no longer depends on υ or
σ. Let us consider R1 = 1.6 and R2 = 1.5 implies β1 = 83.65 and
β2 = 78.42
In this case, the behavior of both diseases is independent, see Fig.
4. The frequency of the RSV peaks is the same in all cases and the
frequency of influenza peaks increases when the effective vaccination
rate is increased.
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Figure 4: Power Spectral Density for the case σ = 1. Parameter values are
σ = 1.0, β1 = 83.65 and β2 = 78.42.
Case σ > 1. Let us consider the case when σ = 1.1, that means that
the presence of one pathogen enhances the presence of the second
one. Thus, the vaccination rate not only changes the period of the
influenza peak but also produces small changes in the RSV peak period.
Figure 5 provides evidence that vaccination affects both influenza
and RSV total amplification. Total amplification corresponds to the
integral of the PSD over all frequencies. This phenomenon is observed
when σ is less and greater than one. After several experiments, we
noticed that in some cases, by increasing the vaccination rate, we reduce
the amplification of influenza but it can be amplified that of the RSV,
see Fig. 3 when υ ≈ 0.0083 and Fig. 5 when υ ≥ 0.0073.
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Figure 5: Total Amplification for both pathogens. Parameter values: R1 =
1.8, β1 = 93.88 year
−1, R2 = 1.5, β2 = 78.23 year−1, σ = 1.1. AInf and
ARSV correspond to the total amplification of influenza and RSV respectively.
They are calculated with different vaccination rate values (υ)
4 Discussion
There is evidence that before the introduction of influenza vaccination
programs, seasonal patterns of RSV and influenza were regular, with an
outbreak of RSV immediately followed by an influenza outbreak each
year [4]. But, in the presence of vaccination against influenza either
pathogen might invade first, see [23, 28]. Our analysis supports the claim
that early season pathogen replacement depends on effective vaccination rate
and relative virus fitness, e.g., R1 and R2. Vaccination changes the natural
frequency and relative fitness of both virus, thus allowing either virus to
peak first in a given season. If the strength of influenza infection (R1) is
greater than the strength of the RSV infection (R2) and the vaccination
rate is small, then the influenza peak can happen first. Otherwise, if the
vaccination rate is large enough the RSV peak might happen first, even
when R1 > R2. However, the peak of RSV will appear first if R2 > R1.
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Figure 6: PSD Correlation as a measure of stochastic amplification
among pathogens. Given fixed basic reproductive numbers for
influenza (R1 = 1.6), and RSV (R2 = 1.4), we show from left
to right, from top to bottom PSD Correlation at vaccination rates
υ = (0, 0.0036, 0.0091, 0.018, 0.025, 0.036) year−1. This figure shows the
correlation between the two pathogen amplifications when σ is varied and
how the frequency for both viruses change when υ increase. For σ = 1 they
are completely independent.
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Previous results [5, 23, 29] support the existence of interference between
outbreaks of RSV infection and influenza. We include the term σ in the
model to explore the immunity relationship between pathogens at the
population level.
When σ 6= 1 there is a correlation in the fluctuations of both diseases as
we can see in Figure 6. Consequently, partial vaccination not only affects the
behavior of influenza but also the behavior of RSV. Of note, according to
the model, it becomes possible to eradicate RSV when σ < 1 by increasing
the rate of vaccination, even if vaccination is directed only against influenza.
On the other hand, σ = 1 means that there is not immunity relation
between the pathogens. In this case, we can vanish influenza by increasing
the vaccination rate without having any effect on RSV. Moreover, when
σ ≈ 1 and R1 ≈ R2, the periodicity of both diseases are similar and there is
an overlap giving the shape of M that we can see in real time series [5], [23].
But, when R1 and R2 have a considerable difference or σ is far from one,
the peaks have a totally different period.
Another important factor is the seasonal forcing. Influenza and RSV
are seasonally related [20], [9]. Circulation of both often occur at similar
times of the year in some temperate zones and peaks timing differ by less
than one month [9], [33]. Seasonality can induce epidemic cycles. When
this is included in the model, the peaks periodicity are not affected but,
non-seasonal peaks appear in frequencies m/T ±|Im(ϑ)|/2pi. We predict the
number and position of the dominant and non-seasonal peaks as a function
of the epidemiological parameters.
Finally, we consider that our analysis might serve as a basis to explore
further the effect of partial vaccination on multi-pathogen epidemics. Of
particular importance is to study the effect of vaccination aiming at reducing
the morbidity caused by respiratory diseases.
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Supplementary Material: Early pathogen
replacement in a model of Influenza and
Respiratory Syncytial Virus with partial
vaccination. A computational study
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In this supplementary material we describe the complete reactions and
the matrices used to obtain the master equation and the expression for the
power spectral density for a two-pathogen system.
1 Model
Equations 1 correspond to the mean field of the system presented in Fig. 1
in the main paper.
˙XSS(t) = µΩ− β2λ2XSS − β1λ1XSS − µXSS − υXSS
˙XIS(t) = β1λ1XSS − γXIS − µXIS − σβ2λ2XIS
˙XRS(t) = γXIS − σβ2λ2XRS − µXRS + υXSS
˙XSI(t) = β2λ2XSS − γXSI − µXSI − σβ1λ1XSI
˙XRI(t) = σβ2λ2XRS − (γ + µ)XRI + γXII
˙XSR(t) = γXSI − µXSR − σβ1λ1XSR
˙XIR(t) = σβ1λ1XSR − (γ + µ)XIR + γXII
˙XRR(t) = γXSR + γXRI − µXRR
X˙II(t) = σβ1λ1XSI + σβ2λ2XIS − (µ+ 2γ)XII
(1)
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where λ1 = (XIS + XII + XIR)/Ω is the proportion of infected people
with virus one (influenza), and λ2 = (XSI +XII +XRI)/Ω is the proportion
of infected people with virus two (RSV). The meaning of the parameters and
variables are described in the main document. To simplify the calculation
we take a new Markov jump process Y (t) whose elements are defined by the
Markov process X(t) above [1, 2] using the following identities.
Y1(t) = XSS(t)
Y2(t) = XIS(t) +XII +XIR(t)
Y3(t) = XSI(t) +XII +XRI(t)
Y4(t) = XIS(t) +XRS(t)
Y5(t) = XSI(t) +XSR(t)
with this simplification we get a new system of differential equations from
Eqs. (1) given by
y˙1(t) = −β2y3y1 − β1y2y1 − υy1 + µ(Ω− y1)
y˙2(t) = β1y2(y1 + σy5)− (γ + µ)y2
y˙3(t) = β2y3(y1 + σy4)− (γ + µ)y3
y˙4(t) = υy1 + β1y2y1 − σβ2y3y4 − µy4
y˙5(t) = β2y3y1− β1σy2y5 − µy5
(2)
y(t) = [y1(t), . . . , y5(t)] correspond to the realization of the stochastic
vector Y (t) = [Y1, . . . , Y5(t)]. To model the presence of stochasticity, we
translate the system of ordinary differential equations definded above (2)
into a stochastic process model. We do this by considering each flux between
compartments to be random. Possible reactions are listed below:
2
Reactions Propensity Stoichiometric vector
µ→ Y1 a1(x) = µΩ + o(∆t) v1 = [1, 0, 0, 0, 0]
Y1 → Y2 a2(x) = β1y1y2 + o(∆t) v2 = [−1, 1, 0, 1, 0]
Y1 → Y3 a3(x) = β2y1y3 + o(∆t) v3 = [−1, 0, 1, 0, 1]
Y1 → µ a4(x) = µy1 + o(∆t) v4 = [−1, 0, 0, 0, 0]
Y1 → Y4 a5(x) = υy1 + o(∆t) v5 = [−1, 0, 0, 1, 0]
Y2 → Y4 a6(x) = γy2 + o(∆t) v6 = [0,−1, 0, 0, 0]
Y2 → µ a7(x) = µy2 + o(∆t) v7 = [0,−1, 0, 0, 0]
Y5 → Y2 a8(x) = σβ1y5y2 + o(∆t) v8 = [0, 1, 0, 0,−1]
Y4 → Y3 a9(x) = σβ2y2y4 + o(∆t) v9 = [0, 0, 1,−1, 0]
Y3 → Y5 a10(x) = γy3 + o(∆t) v10 = [0, 0,−1, 0, 0]
Y3 → µ a11(x) = µy3 + o(∆t) v11 = [0, 0,−1, 0, 0]
Y4 → µ a12(x) = µy4 + o(∆t) v12 = [0, 0, 0,−1, 0]
Y5 → µ a13(x) = µy5 + o(∆t) v13 = [0, 0, 0, 0,−1]
Table 1: List of reactions and stochiometric vectors for system (2).
The master equation is given by
Py(t) =
R∑
i1
{ai(y − vi)Py−vi(t)− ai(y)Py(t)} (3)
The stochiometric vectors vi and the rate of reactions ai, i = 1, . . . ,R are
presented in Tab. 1. The van Kampen expansion [4] writes the number of
individuals as a sum of two parts
Yk(t) = Ωφk(t) + Ω
1/2ξk(t) (4)
where φk(t), k = 1, . . . , 5 describes the macroscopic behaviour. ξk(t)
represents the aggregate effects of demographic stochasticity and describes
the fluctuations. We expand in power of Ω and collect powers of Ω1/2 to find
the macroscopic law given by
dφk
dt
=
R∑
i=1
Skijf
′
i(φ)
dφ
dt
= Sf(φ)
3
where S = [v1, . . . , vR] is the stoichiometric matrix and f(φ) =
[a1(φ), . . . , aR(φ)] is the vector with propensities. We set η1 = η2 = 0. The
expressions for the scaled macroscopic equations are:
φ˙1(t) = −β2φ3φ1 − β1φ2φ1 − υφ1 + µ(1− φ1)
φ˙2(t) = β1φ2(φ1 + σφ5)− (γ + µ)φ2
φ˙3(t) = β2φ3(φ1 + σφ4)− (γ + µ)φ3
φ˙4(t) = υφ1 + β1φ2φ1 − σβ2φ3φ4 − µφ4
φ˙5(t) = β2φ3φ1 − β1σφ2φ5 − µφ5
(5)
To take into account the demographic stochasticity we will use the
unscaled system:
φ˙1(t) = −β2φ3
Ω
φ1 − β1φ2
Ω
φ1 − υφ1 + µ(Ω− φ1)
φ˙2(t) = β1
φ2
Ω
(φ1 + σφ5)− (γ + µ)φ2
φ˙3(t) = β2
φ3
Ω
(φ1 + σφ4)− (γ + µ)φ3
φ˙4(t) = υφ1 + β1
φ2
Ω
φ1 − σβ2φ3
Ω
φ4 − µφ4
φ˙5(t) = β2
φ3
Ω
φ1 − β1σφ2
Ω
φ5 − µφ5
(6)
Then, we collect powers of Ω0 to obtain a set of Langevin equations
ξ˙(t) = A(t)ξ(t) + ζ(t) (7)
ζ(t) is the white noise with zero mean and its cross-correlation structure
is given by 〈ζ(t)ζ(t′)T 〉 = B(t)δ(t− t′).
Matrices A and B
Matrix A(t) is represented by A = S.
∂f(φ)
∂φ
which is equivalent to the
Jacobian of system (6); matrix B(t) is given by B = Sdiag(f(φ))ST .
4
Matrix A
−β1φ2
Ω
− β2φ3
Ω
− υ − µ −β1φ1
Ω
−β2φ1
Ω
0 0
β1
φ2
Ω
β1
Ω
(φ1 + φ5σ)− γ − µ 0 0 β1φ2
Ω
σ
β2
φ3
Ω
0
β2
Ω
(φ1 + φ4σ)− γ − µ β2φ3
Ω
σ 0
β1
φ2
Ω
+ υ β1
φ1
Ω
−β2φ4
Ω
σ −β2φ3
Ω
σ − µ 0
β2
φ3
Ω
−β1φ5
Ω
σ β2
φ1
Ω
0 −β1φ2
Ω
σ − µ

Matrix B
β1φ1
φ2
Ω
+ υφ1 −β1φ1φ2
Ω
−β2φ1φ3
Ω
−β1φ1φ2
Ω
− υφ1 −β2φ1φ3
Ω
+β2φ1
φ3
Ω
+ µφ1 + µ
−β1φ1φ2
Ω
β1φ1
φ2
Ω
+ γφ2+ 0 β1φ1
φ2
Ω
−β1σφ2φ5
Ω
β1σφ2
φ5
Ω
+ µφ2
−β2φ1φ3
Ω
0 β2φ1
φ3
Ω
+ γφ3 + µφ3+ −β2σφ3φ4
Ω
β2φ1
φ3
Ω
β2σφ3
φ4
Ω
−β1φ1 φ2Ω − υφ1 β1φ1
φ2
Ω
−β2σφ3φ4
Ω
β1φ1
φ2
Ω
+ υφ1+ 0
β2σ
φ3
Ω
φ4 + µφ4
−β2φ1φ3
Ω
−β1σφ2φ5
Ω
β2φ1
φ3
Ω
0 β2φ1
φ3
Ω
+
β1σφ2
φ5
Ω
+ µφ5

1.1 Equilibrium Points
System (6) has four fixed points, we can find only two analytically.
Let φ1(t) = φ2(t) = 0. The disease-free equilibrium point is given by:
φ10 = Ω
[
µ
(µ+ υ)
, 0, 0,
υ
(µ+ υ)
, 0
]
(8)
Now, let φ3(t) = 0. The equilibrium with people infected with influenza
only is
φ20 = Ω
[
γ + µ
β1
,
µ
γ + µ
− υ + µ
β1
, 0, 1− γ + µ
β1
, 0
]
(9)
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1.2 The Reproduction Number:
In the system (5), φ1 and φ2 correspond to the infection states. Matrix F
and V in the scaled equilibrium point (φ10/Ω) are given by
F =
1
(υ + µ)
β1µ 0
0
β2(µ+ συ)
µ+ υ
; V = ((γ + µ) 0
0 (γ + µ)
)
We refer the reader to Van den Driessche et al. [3] for further details about
R0 calculation. The next generation matrix, FV
−1, has two eigenvalues given
by:
R1 =
µβ1
(γ + µ)(µ+ υ)
; R2 =
β2(µ+ συ)
(γ + µ)(µ+ υ)
The two eigenvalues correspond to the reproduction numbers for each
pathogen, R1 for influenza and R2 for RSV. The maximum of the two is the
basic reproduction number for the system is. Thus
R0 = max
p=1,2
Rp (10)
The equilibrium point φ10 is stable if R0 < 1 [3]-, this implies that R1 < 1
and R2 < 1.
2 Power Spectral Density Computation
2.1 Unforced Model
Algorithm 1: PSD - Unforced Model
Data: Parameters values p, discretization of frecuency (ω)
Result: PSDk array ( dim(PSDk) = (1× len(Y ))
begin
Find the stable equilibrium point of system (6) (φ0)
Evaluate matrix A and B in p and φ0
for j in ω do
Compute matrix Φ(ωj) = −iωjI − A
Compute matrix P (ωj) = Φ(ω)BΦ
†(ω)
Save PSDk(ωj) = Re(Pkk(ωj)) for k = 1, . . . , dim(φ)
6
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